MAPT and Alzheimer disease: The first-generation Tau tracer THK5117 has a distinct laminar binding pattern in some cortical areas in patients with AD, even if tau binding cannot be detected in people with DS before the age of 30; it is unknown whether this is due to PET sensitivity limitations or reduced binding to certain forms of pathological Tau.